Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Aufsätze"
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Systemic+lupus+erythematosus%22&type=Subject
PubPharm (1.642)
1
Study the efficacy and safety of VAY736 and CFZ533 in patients with systemic lupus erythematosus (SLE) : A placebo-controlled, patient and investigator blinded, randomized parallelcohort study to assess pharmacodynamics, pharmacokinetics, safety,tolerability and preliminary clinical efficacy of VAY736 and CFZ533 inpatients with systemic lupus erythematosus (SLE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
RIvaroxaban for Stroke patients with AntiPhospholipid Syndrome : Rivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE (RISAPS): a randomised, controlled, open-label, phase II/III, non-inferiority trial - RIvaroxaban for Stroke patients with AntiPhospholipid Syndrome
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Phase IIb study of IFN-K in Systemic Lupus Erythematosus : A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNa-Kinoid in Adult Subjects with Systemic Lupus Erythematosus - Phase IIb study of IFN-K in Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Phase IIb study of IFN-K in Systemic Lupus Erythematosus : A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNa-Kinoid in Adult Subjects with Systemic Lupus Erythematosus - Phase IIb study of IFN-K in Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Study the efficacy and safety of VAY736 and CFZ533 in patients with systemic lupus erythematosus (SLE) : A placebo-controlled, patient and investigator blinded, randomized parallelcohort study to assess pharmacodynamics, pharmacokinetics, safety,tolerability and preliminary clinical efficacy of VAY736 and CFZ533 inpatients with systemic lupus erythematosus (SLE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A study to evaluate the efficacy and safety of Anifrolumab compared to placebo in adult patients with Active Systemic Lupus Erythematosus : A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[165]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
Aufsätze
1.642
E-Artikel
1.642
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.642
610
1.416
Study Type: Interventional
820
Recruitment Status: Not yet recruiting
444
Phase: Phase 2
312
Phase: Phase 3
266
Recruitment Status: Authorised-recruitment may ...
260
Recruitment Status: Recruiting
204
Study Type: Observational
174
Recruitment Status: Completed
88
Medical Condition: Systemic lupus erythematosus
72
Medical Condition: Systemic Lupus Erythematosus
58
Medical Condition: systemic lupus erythematosus
42
Recruitment Status: Complete: follow-up complete
38
Medical Condition: Systemic Lupus Erythematosus...
38
Medical Condition: Systemic lupus erythematosus...
36
Medical Condition: Systemic Lupus Erythematosus...
34
Medical Condition: -M32 Systemic lupus erythema...
34
Phase: Phase 1
32
Medical Condition: Systemic Lupus Erythematosus...
32
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
998
2020-
644
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.610
Englisch
20
Unbestimmt
10
Spanisch
2
Italienisch
Haven't found what you're looking for?
Wird geladen...